Women, power, and cancer: a Lancet Commission

O Ginsburg, V Vanderpuye, AM Beddoe, N Bhoo-Pathy… - The Lancet, 2023 - thelancet.com
Executive summary Women interact with cancer in complex ways, as healthy individuals
participating in cancer prevention and screening activities, as individuals living with and …

Long non-coding RNA/epithelial-mesenchymal transition axis in human cancers: Tumorigenesis, chemoresistance, and radioresistance

M Hashemi, S Hajimazdarany, CD Mohan… - Pharmacological …, 2022 - Elsevier
Epithelial-to-mesenchymal transition (EMT) is a process that involves the transformation of
polarized epithelial cells to attain a mesenchymal phenotype that presents an elevated …

Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population

KT Simms, A Keane, DTN Nguyen, M Caruana… - Nature Medicine, 2023 - nature.com
Abstract In 2020, the World Health Organization (WHO) launched a strategy to eliminate
cervical cancer as a public health problem. To support the strategy, the WHO published …

CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs

L Zhang, I Mosquera, E Lucas, ML Rol, AL Carvalho… - Nature medicine, 2023 - nature.com
The CanScreen5 project is a global cancer screening data repository that aims to report the
status and performance of breast, cervical and colorectal cancer screening programs using …

Diagnostic accuracy of cervical cancer screening strategies for high-grade cervical intraepithelial neoplasia (CIN2+/CIN3+) among women living with HIV: A …

H Kelly, I Jaafar, M Chung, P Michelow, S Greene… - …, 2022 - thelancet.com
Background We systematically reviewed the diagnostic accuracy of cervical cancer
screening and triage strategies in women living with HIV (WLHIV). Methods Cochrane …

Associated factors and global adherence of cervical cancer screening in 2019: a systematic analysis and modelling study

W Zhang, K Gao, FJI Fowkes, D Adeloye, I Rudan… - Globalization and …, 2022 - Springer
Background Cervical cancer screening is vital for its prevention. Adherence is a crucial
indicator that implies the individual willingness to take cervical cancer screening. We aimed …

Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study

I Man, D Georges, TM de Carvalho… - The Lancet …, 2022 - thelancet.com
Background Despite the high burden of cervical cancer, access to preventive measures
remains low in India. A single-dose immunisation schedule could facilitate the scale-up of …

Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study

AT Ramírez, J Valls, A Baena, FD Rojas… - The Lancet Regional …, 2023 - thelancet.com
Background Cervical cytology remains widely used as the initial tool in cervical cancer
screening worldwide. WHO guidelines recommend replacing cytology with primary HPV …

In-silico study unveils potential phytocompounds in Andrographis paniculata against E6 protein of the high-risk HPV-16 subtype for cervical cancer therapy

MA Islam, MS Hossain, S Hasnat, MH Shuvo, S Akter… - Scientific Reports, 2024 - nature.com
Despite therapeutic advancements, cervical cancer caused by high-risk subtypes of the
human papillomavirus (HPV) remains a leading cause of cancer-related deaths among …

Predicting cervical cancer biopsy results using demographic and epidemiological parameters: a custom stacked ensemble machine learning approach

K Chadaga, S Prabhu, N Sampathila… - Cogent …, 2022 - Taylor & Francis
The human papillomavirus (HPV) is responsible for most cervical cancer cases worldwide.
This gynecological carcinoma causes many deaths, even though it can be treated by …